Booster Vaccine
-
{
- All
- News
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
China Needs "Good Covid Booster" Like Covovax, Says Adar Poonawalla
China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
-
Moderna Seeks Emergency Approval For Second Covid Booster For US Adults
Moderna announced Thursday it had asked the United States drug regulator for emergency authorization for a second booster shot of the company's Covid-19 vaccine for all adults.
-
Booster No Later Than 3 Months After Two Doses, Says France
France on Friday recommended that adults receive a Covid-19 booster vaccination three months after their initial jabs, reducing the current guideline of five months to better fight the Omicron variant.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
Scientific Reasoning For Booster Vaccine Doses Under Examination: Centre
Scientific reasoning for booster vaccine doses for COVID-19 is under examination but the priority is to ensure complete vaccination of the eligible population with both doses, the government said on Thursday.
-
"Evolving Science": Centre On Booster Doses Of Covid Vaccines
The science relating to the use of booster doses of COVID-19 vaccines is still evolving and the developments are being closely watched, the government said on Thursday.
-
WHO Urges "Moratorium" On Covid Vaccine Booster Shots Till End Of Year
The World Health Organization called Wednesday for countries to avoid giving out extra Covid jabs until year-end, pointing to the millions worldwide who have yet to receive a single dose.
-
Looking Very Deeply Into Issue Of Vaccine Booster Dose: NITI Aayog Member
The national expert committee on COVID-19 vaccination has discussed the issue of giving booster vaccine dose and it is being looked into very deeply, NITI Aayog Member (Health) Dr VK Paul said on Tuesday.
-
AstraZeneca Tests Booster Vaccine Against Beta Variant Of Covid
AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa.
-
Cipla Close To Committing Over $1 Billion For Moderna Booster Vaccine In India: Report
Seeking fast-track approvals to bring Moderna's single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
China Needs "Good Covid Booster" Like Covovax, Says Adar Poonawalla
China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.
-
Moderna Seeks Emergency Approval For Second Covid Booster For US Adults
Moderna announced Thursday it had asked the United States drug regulator for emergency authorization for a second booster shot of the company's Covid-19 vaccine for all adults.
-
Booster No Later Than 3 Months After Two Doses, Says France
France on Friday recommended that adults receive a Covid-19 booster vaccination three months after their initial jabs, reducing the current guideline of five months to better fight the Omicron variant.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
Scientific Reasoning For Booster Vaccine Doses Under Examination: Centre
Scientific reasoning for booster vaccine doses for COVID-19 is under examination but the priority is to ensure complete vaccination of the eligible population with both doses, the government said on Thursday.
-
"Evolving Science": Centre On Booster Doses Of Covid Vaccines
The science relating to the use of booster doses of COVID-19 vaccines is still evolving and the developments are being closely watched, the government said on Thursday.
-
WHO Urges "Moratorium" On Covid Vaccine Booster Shots Till End Of Year
The World Health Organization called Wednesday for countries to avoid giving out extra Covid jabs until year-end, pointing to the millions worldwide who have yet to receive a single dose.
-
Looking Very Deeply Into Issue Of Vaccine Booster Dose: NITI Aayog Member
The national expert committee on COVID-19 vaccination has discussed the issue of giving booster vaccine dose and it is being looked into very deeply, NITI Aayog Member (Health) Dr VK Paul said on Tuesday.
-
AstraZeneca Tests Booster Vaccine Against Beta Variant Of Covid
AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa.
-
Cipla Close To Committing Over $1 Billion For Moderna Booster Vaccine In India: Report
Seeking fast-track approvals to bring Moderna's single-dose COVID-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty.
